Thomas Cecil Lachman
CIK: 0002092589
Associated companies
Transaction History
| HHH | ▲ Buy | Grant | 3,290 | $0 | 6/19/2026 | View on chart |
| HHH | ▲ Buy | Grant | 2,464 | $0 | 10/24/2025 | View on chart |
| HHH | ▲ Buy | Grant | 3,290 | $0 | 6/19/2026 | View on chart |
| HHH | ▲ Buy | Grant | 2,464 | $0 | 10/24/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Howard Hughes Holdings Q2 Earnings and Analyst Updates
Howard Hughes Holdings reported its Q2 2026 earnings, with the stock currently down 9.3% year-to-date. Piper Sandler maintained an Overweight rating but lowered its price target to $83. The company also announced the dates for its upcoming Q3 2026 earnings release and conference call.
Howard Hughes Holdings Q2 Earnings and Analyst Updates. Howard Hughes Holdings reported its Q2 2026 earnings, with the stock currently down 9.3% year-to-date. Piper Sandler maintained an Overweight rating but lowered its price target to $83. The company also announced the dates for its upcoming Q3 2026 earnings release and conference call.